Ellie Collins

Our first not-for-profit game app Dr Bug: Microbe Mayhem! was launched at the Oxfordshire Science Festival on 17–18 June 2017 to raise awareness about antibiotic resistance. You can download the free app to your iPad or Android phone/tablet here.

Monday 15 May was International MPS Awareness Day.

Oxford PharmaGenesis recently attended the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held in Boston, MA, USA on 20–24 May 2017.

We were busy at last month’s European Medical Writers Association Conference in Birmingham, UK. Chris Winchester, our Managing Director, led an Expert Seminar Series workshop, a Joint Position Statement launch seminar and presented a poster.

Oxford PharmaGenesis joined this year’s International Society for Medical Publication Professionals (ISMPP) Annual Meeting, which attracted more than 550 publication professionals from the pharmaceutical industry, medical communications agencies and publishers.

Oxford PharmaGenesis has been named as one of the ‘1000 Companies to Inspire Britain’ in a report published this week by the London Stock Exchange Group.

At the April MedComms Brunch Club in Oxford, expert insights into the latest trends and industry updates were presented by Dr Chris Winchester, our Managing Director, Dr Paul Farrow, Communications Director, and Saundra Hemmings, Project Manager.

Oxford PharmaGenesis Commercial Director Dr Richard White was Chairman of the 16th Annual Meeting of The International Publication Planning Association (TIPPA), held in San Diego, USA on 21–22 February 2017, and provides his insights on the conference.

Teams across the Oxford PharmaGenesis offices have been celebrating Pi Day after more than 100 of us registered with ORCID, joining a community of over 3.14 million people who share the vision of transparency and trust in research and innovation.

As a leading healthcare communications company and a proud member of the Reciprocate network, Oxford PharmaGenesis takes its corporate social responsibilities very seriously.